Coegin Pharma AB (NGM:COEGIN)

Coegin Pharma AB Earnings Call Transcripts

Fiscal Year 2024

• Status Update

  Follicopeptide, a novel hair growth peptide, is set for a Q4 2025 launch in Europe and the U.S., with production and regulatory processes on schedule. Clinical studies show over 70% efficacy, and commercialization will occur through established partners.

  Read full transcript →

Data Source: Quartr Last updated: Dec 18, 2024

Earnings call transcripts are provided by Quartr and are published within hours after each earnings call.

Update frequency:

Quarterly

Data Sources Report a data error

Stock Analysis Pro

Upgrade now for unlimited access to all data and tools.

Market Newsletter

Get a daily email with the top market news in bullet point format.